Arovella Therapeutics Ltd Price, Chart & Factor Analysis
Free Data & Analytics AccessArovella Therapeutics Ltd Forecast
Arovella Therapeutics Ltd short-term momentum is strongly negative (up over 0 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is strongly negative (0 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 44.1% a year, a typical one-standard-deviation range is 0.0422–0.0478 over a week, 0.0393–0.0507 over a month and 0.0252–0.0648 over a year. (Signals as of 21 Nov 2026.)
Arovella Therapeutics Ltd Price Chart
Arovella Therapeutics Ltd Factors
Research on Arovella Therapeutics Ltd
Explore MacroFinance macro & markets research and analysis.
Arovella Therapeutics Ltd Trading Strategies
31 backtested tactical asset allocation strategies hold EFA (developed markets outside the US), the closest tradable exposure to Arovella Therapeutics Ltd; 22 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in EFA | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Movement Capital's Composite Strategy | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Butler's Elastic Asset Allocation - Defensive | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Butler's Elastic Asset Allocation - Offensive | Aggressive | Monthly | Premium · upgrade to view | |||
| Momentum Turning Points | Conservative | Monthly | Premium · upgrade to view | |||
| Keller, Butler and Kipnis' Classical Asset Allocation - Offensive | Moderate | Monthly | Premium · upgrade to view | |||
| Financial Mentor's All-Weather Quad Momentum | Aggressive | Monthly | Premium · upgrade to view | |||
| Keller, Butler and Kipnis' Classical Asset Allocation - Defensive | Moderate | Monthly | Premium · upgrade to view | |||
| Livingston's Mama Bear (Muscular Portfolios) | Aggressive | Monthly | Premium · upgrade to view | |||
| Meb Faber's Global Tactical Asset Allocation 13 (GTAA 13) | Conservative | Monthly | Premium · upgrade to view | |||
| David Varadi's Minimum Correlation Portfolio | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
Statistical Distribution of Returns
PlusHow Arovella Therapeutics Ltd’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Arovella Therapeutics Ltd (Australia)
Arovella Therapeutics Ltd is a listed security in Australia. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on AltaGas Ltd
Frequently asked questions
What is Arovella Therapeutics Ltd?
What is the latest Arovella Therapeutics Ltd price?
Is Arovella Therapeutics Ltd in an uptrend?
How volatile is Arovella Therapeutics Ltd?
What factors affect Arovella Therapeutics Ltd?
Which trading strategies trade Arovella Therapeutics Ltd?
How are Arovella Therapeutics Ltd returns analysed?
Where can I download free Arovella Therapeutics Ltd historical data?
Free Arovella Therapeutics Ltd historical data (last 10 years)
Browse or instantly download the last 10 years of Arovella Therapeutics Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.ALA.AU&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 0.045 |
| 2026-11-19 | 0.049 |
| 2026-11-18 | 0.05 |
| 2026-11-17 | 0.05 |
| 2026-11-16 | 0.049 |
| 2026-11-13 | 0.049 |
| 2026-11-12 | 0.049 |
| 2026-11-11 | 0.051 |
| 2026-11-10 | 0.05 |
| 2026-11-09 | 0.05 |
About this stock
Arovella Therapeutics Limited, a biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally. It product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukaemias; ALA-105 CLDN18.2 for targeting Claudin 18.2, which is expressed in gastric cancer, gastroesophageal junction cancer, pancreatic cancer, and lung and ovarian cancer; and IL-12-TM for treating solid tumors. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is based in Preston, Australia.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.